BioMarin Pharmaceutical Inc. (BMRN) PT Raised to $126 at Piper Sandler; 'Strong Execution All Around'
Tweet Send to a Friend
Piper Sandler analyst Christopher Raymond raised the price target on BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) to $126.00 (from $122.00) while ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
